Bersanlimab (Anti-ICAM1 / CD54)
Bersanlimab (Anti-ICAM1 / CD54) (A2464-GRP)
Products
Description
Bersanlimab (Anti-ICAM1 / CD54) is a fully human monoclonal antibody that targets intercellular adhesion molecule-1 (ICAM-1 or CD54). Bersanlimab has anticancer effects. MW: 145.5 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2464 |
| Target | Integrin |